Recently, I had the opportunity to interview Pete O’Heeron, CEO of a private company called SpinalCyte, a company developing an application to treat degenerative disc disease using cells derived from human skin for the Nov. 9th edition of Medical Device…
We have been hearing a lot about the death of innovation in the field of medical technology for the past few years, a victim; it would appear, of a sluggish worldwide economy and more stringent regulation and reimbursement policies. However,…
A couple of weeks ago I interviewed PixelOptics‘ president/CEO Ron Blum, about a technology called emPower, a device that could eventually replace bifocals.
